JP Morgan Chase Portfolio holdings
JPMorgan Chase & Co., formed by the 2000 merger of J.P. Morgan & Co. and Chase Manhattan Bank, is a global financial services giant headquartered in New York City, tracing its roots back to 1799 through its predecessor firms. As one of the largest banks in the world, it operates across investment banking, commercial banking, asset management, and consumer banking, managing trillions in assets and serving millions of customers, corporations, and governments. Led by CEO Jamie Dimon since 2005, the firm is renowned for its role in high-profile deals, robust trading operations, and its Chase retail banking network, which includes extensive credit card and mortgage services. Combining a legacy of financial innovation with a dominant market presence, JPMorgan Chase remains a cornerstone of the global economy.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
JPMorgan BetaBuilders Europe ETF
BBEU
|
+$3.58B |
| 2 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$2.7B |
| 3 |
Apple
AAPL
|
+$1.71B |
| 4 |
Schwab Short-Term US Treasury ETF
SCHO
|
+$1.57B |
| 5 |
Meta Platforms (Facebook)
META
|
+$1.51B |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$1.51B |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$1.23B |
| 3 |
State Street Financial Select Sector SPDR ETF
XLF
|
+$920M |
| 4 |
Alphabet (Google) Class A
GOOGL
|
+$817M |
| 5 |
iShares 7-10 Year Treasury Bond ETF
IEF
|
+$794M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 26.23% |
| 2 | Technology | 15.68% |
| 3 | Financials | 11.13% |
| 4 | Consumer Discretionary | 9.78% |
| 5 | Healthcare | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
|
ANZUU
4601
DELISTED
Anzu Special Acquisition Corp I Units
ANZUU
| $435K | ﹤0.01% |
43,499
-6,501
| -13% | -$64.9K |
2021 Q1
1 quarter
|
|
4602
Rhythm Pharmaceuticals
RYTM
$6.43B
| $434K | ﹤0.01% |
22,169
-57,656
| -72% | -$1.2M |
2017 Q4
14 quarters
|
|
4603
KALA BIO
KALA
$8.11M
| $433K | ﹤0.01% |
33
+1
| +3% | +$15.7K |
2017 Q3
15 quarters
|
|
4604
CALL
Pultegroup
PHM
$22.2B
| $431K | ﹤0.01% |
7,900
-1,136,900
| -99% | -$63.6M |
2021 Q1
1 quarter
|
|
|
CHMA
4605
DELISTED
Chiasma, Inc. Common Stock
CHMA
| $431K | ﹤0.01% |
91,247
-31,693
| -26% | -$119K |
2018 Q4
10 quarters
|
|
|
B
4606
CALL
Barrick Mining
B
$66B
| $430K | ﹤0.01% |
20,800
| – | – |
2021 Q1
1 quarter
|
|
|
FRSX
4607
Foresight Autonomous Holdings
FRSX
$4.5M
| $428K | ﹤0.01% |
+800
| New | +$458K |
2021 Q2
0 quarters
|
|
|
GCMGW
4608
DELISTED
GCM Grosvenor Inc Warrant
GCMGW
| – | – |
0
| – | – |
2021 Q1
1 quarter
|
|
4609
iRadimed
IRMD
$1.09B
| $428K | ﹤0.01% |
14,550
-9,037
| -38% | -$249K |
2016 Q3
19 quarters
|
|
|
RNAM
4610
DELISTED
Avidity Biosciences
RNAM
| $427K | ﹤0.01% |
17,278
+2,139
| +14% | +$49.8K |
2020 Q3
3 quarters
|
|
|
AFMD
4611
DELISTED
Affimed
AFMD
| $426K | ﹤0.01% |
5,014
-5,786
| -54% | -$528K |
2019 Q2
8 quarters
|
|
4612
Hovnanian Enterprises
HOV
$685M
| $426K | ﹤0.01% |
4,002
+3,986
| +24,913% | +$463K |
2020 Q4
2 quarters
|
|
4613
National Bankshares
NKSH
$270M
| $426K | ﹤0.01% |
12,174
-11,384
| -48% | -$402K |
2017 Q4
14 quarters
|
|
4614
Invesco FTSE RAFI US 1000 ETF
PRF
$9.8B
| $426K | ﹤0.01% |
13,285
| – | – |
2018 Q3
11 quarters
|
|
|
IHC
4615
DELISTED
Independence Holding Company
IHC
| $426K | ﹤0.01% |
9,190
-9,510
| -51% | -$422K |
2017 Q4
14 quarters
|
|
|
SUP
4616
DELISTED
Superior Industries International
SUP
| $425K | ﹤0.01% |
49,314
+42,437
| +617% | +$291K |
2015 Q4
22 quarters
|
|
|
CORR
4617
DELISTED
CorEnergy Infrastructure Trust, Inc.
CORR
| $425K | ﹤0.01% |
64,250
+16,352
| +34% | +$105K |
2016 Q2
20 quarters
|
|
|
GORV
4618
DELISTED
Lazydays
GORV
| $424K | ﹤0.01% |
643
+478
| +290% | +$326K |
2020 Q2
4 quarters
|
|
4619
Babcock & Wilcox
BW
$863M
| $423K | ﹤0.01% |
53,716
+45,728
| +572% | +$378K |
2020 Q2
4 quarters
|
|
4620
Merchants Bancorp
MBIN
$2.27B
| $423K | ﹤0.01% |
16,166
-25,422
| -61% | -$705K |
2017 Q4
14 quarters
|
|
|
MILE
4621
DELISTED
Metromile, Inc. Common Stock
MILE
| $423K | ﹤0.01% |
+46,244
| New | +$414K |
2021 Q2
0 quarters
|
|
|
AGEN
4622
Agenus
AGEN
$376M
| $422K | ﹤0.01% |
3,904
+870
| +29% | +$65.2K |
2017 Q3
15 quarters
|
|
4623
CALL
CF Industries
CF
$17.3B
| $422K | ﹤0.01% |
+8,200
| New | +$417K |
2021 Q2
0 quarters
|
|
|
GNTY
4624
DELISTED
Guaranty Bancshares
GNTY
| $422K | ﹤0.01% |
12,406
-12,067
| -49% | -$459K |
2017 Q4
14 quarters
|
|
4625
iShares MSCI Turkey ETF
TUR
$170M
| $422K | ﹤0.01% |
20,042
-1,129
| -5% | -$26K |
2015 Q1
25 quarters
|
|
Similar funds
JP Morgan Chase's Q2 2021 Portfolio in Review
As of Q2 2021, JP Morgan Chase held 6,872 positions worth $838B, up 12% from $749B the previous quarter. Its ten largest holdings account for 16% of the portfolio.
JP Morgan Chase deployed $31.1B of net new capital in Q2 2021, opening 693 new positions and adding to 2,351 existing holdings. Its largest new stake was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
By sector, the portfolio is most concentrated in Miscellaneous at 26% of assets, up from 26% a quarter earlier, followed by Technology and Financials.
On the sell side, the largest reduction was iShares 20+ Year Treasury Bond ETF, an estimated $1.51B trimmed.
- JP Morgan Chase's largest Q2 2021 buy was DiDi Global Inc. American depositary shares, each four representing one Class A ordinary share: 25,313,889 shares worth $358M.
- JP Morgan Chase added most to JPMorgan BetaBuilders Europe ETF in Q2 2021, an estimated $3.58B increase.
- JP Morgan Chase's biggest Q2 2021 reduction was iShares 20+ Year Treasury Bond ETF, cutting an estimated $1.51B.
- JP Morgan Chase fully exited INPHI CORPORATION in Q2 2021, selling an estimated $333M.
- JP Morgan Chase's ten largest holdings make up 16% of its $838B portfolio in Q2 2021.
- JP Morgan Chase opened 693 new positions and closed 449 in Q2 2021.
- JP Morgan Chase's portfolio value rose 12% quarter-over-quarter to $838B.
Based on JP Morgan Chase's 13F filing for Q2 2021, filed 12 Aug 2021.